During the past decade, Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are "Diffuse Large B-cell Lymphoma" (1 trials) and "Solid Tumours" (1 trials). Many other conditions were trialed in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" in a lesser frequency.

Most popular intervention types in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (1 trials), "Glofitamab" (1 trials), "Obinutuzumab" (1 trials), "Oxaliplatin" (1 trials) and "Rituxumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".